Literature DB >> 24912162

IκB kinase-induced interaction of TPL-2 kinase with 14-3-3 is essential for Toll-like receptor activation of ERK-1 and -2 MAP kinases.

Abduelhakem Ben-Addi1, Agnes Mambole-Dema1, Christine Brender1, Stephen R Martin2, Julia Janzen1, Sven Kjaer3, Stephen J Smerdon4, Steven C Ley5.   

Abstract

The MEK-1/2 kinase TPL-2 is critical for Toll-like receptor activation of the ERK-1/2 MAP kinase pathway during inflammatory responses, but it can transform cells following C-terminal truncation. IκB kinase (IKK) complex phosphorylation of the TPL-2 C terminus regulates full-length TPL-2 activation of ERK-1/2 by a mechanism that has remained obscure. Here, we show that TPL-2 Ser-400 phosphorylation by IKK and TPL-2 Ser-443 autophosphorylation cooperated to trigger TPL-2 association with 14-3-3. Recruitment of 14-3-3 to the phosphorylated C terminus stimulated TPL-2 MEK-1 kinase activity, which was essential for TPL-2 activation of ERK-1/2. The binding of 14-3-3 to TPL-2 was also indispensible for lipopolysaccharide-induced production of tumor necrosis factor by macrophages, which is regulated by TPL-2 independently of ERK-1/2 activation. Our data identify a key step in the activation of TPL-2 signaling and provide a mechanistic insight into how C-terminal deletion triggers the oncogenic potential of TPL-2 by rendering its kinase activity independent of 14-3-3 binding.

Entities:  

Keywords:  MAP3K8; NF-κB; inflammation

Mesh:

Substances:

Year:  2014        PMID: 24912162      PMCID: PMC4060680          DOI: 10.1073/pnas.1320440111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

1.  IL-1-induced NFkappa B and c-Jun N-terminal kinase (JNK) activation diverge at IL-1 receptor-associated kinase (IRAK).

Authors:  X Li; M Commane; Z Jiang; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-03       Impact factor: 11.205

2.  NF-kappaB1 p105 negatively regulates TPL-2 MEK kinase activity.

Authors:  S Beinke; J Deka; V Lang; M P Belich; P A Walker; S Howell; S J Smerdon; S J Gamblin; S C Ley
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

3.  Tumor progression locus 2 (Tpl-2) encodes a protein kinase involved in the progression of rodent T-cell lymphomas and in T-cell activation.

Authors:  C Patriotis; A Makris; S E Bear; P N Tsichlis
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

4.  Tumor progression locus 2 (Map3k8) is critical for host defense against Listeria monocytogenes and IL-1 beta production.

Authors:  Lisa A Mielke; Karen L Elkins; Lai Wei; Robyn Starr; Philip N Tsichlis; John J O'Shea; Wendy T Watford
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

5.  Akt-dependent phosphorylation specifically regulates Cot induction of NF-kappa B-dependent transcription.

Authors:  Lawrence P Kane; Marianne N Mollenauer; Zheng Xu; Christoph W Turck; Arthur Weiss
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

6.  Selective inhibitors of tumor progression loci-2 (Tpl2) kinase with potent inhibition of TNF-alpha production in human whole blood.

Authors:  Junjun Wu; Neal Green; Rajeev Hotchandani; Yonghan Hu; Jeffrey Condon; Adrian Huang; Neelu Kaila; Huan-Qiu Li; Satenig Guler; Wei Li; Steve Y Tam; Qin Wang; Jeffrey Pelker; Suzana Marusic; Sang Hsu; J Perry Hall; Jean-Baptiste Telliez; Junqing Cui; Lih-Ling Lin
Journal:  Bioorg Med Chem Lett       Date:  2009-05-07       Impact factor: 2.823

7.  ABIN-2 forms a ternary complex with TPL-2 and NF-kappa B1 p105 and is essential for TPL-2 protein stability.

Authors:  V Lang; A Symons; S J Watton; J Janzen; Y Soneji; S Beinke; S Howell; S C Ley
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

Review 8.  IκB kinase regulation of the TPL-2/ERK MAPK pathway.

Authors:  Thorsten Gantke; Srividya Sriskantharajah; Michael Sadowski; Steven C Ley
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

9.  Regulation of experimental autoimmune encephalomyelitis by TPL-2 kinase.

Authors:  Srividya Sriskantharajah; Eva Gückel; Niki Tsakiri; Katrin Kierdorf; Christine Brender; Abduelhakem Ben-Addi; Marc Veldhoen; Philip N Tsichlis; Brigitta Stockinger; Anne O'Garra; Marco Prinz; George Kollias; Steven C Ley
Journal:  J Immunol       Date:  2014-03-17       Impact factor: 5.422

10.  Ebola virus VP35 induces high-level production of recombinant TPL-2-ABIN-2-NF-κB1 p105 complex in co-transfected HEK-293 cells.

Authors:  Thorsten Gantke; Sabrina Boussouf; Julia Janzen; Nicholas A Morrice; Steven Howell; Elke Mühlberger; Steven C Ley
Journal:  Biochem J       Date:  2013-06-01       Impact factor: 3.857

View more
  19 in total

1.  Penehyclidine ameliorates acute lung injury by inhibiting Toll-like receptor 2/4 expression and nuclear factor-κB activation.

Authors:  N A Wang; Yue Su; Xiang-Ming Che; Hui Zheng; Zhi-Guo Shi
Journal:  Exp Ther Med       Date:  2016-03-11       Impact factor: 2.447

2.  TPL2 enforces RAS-induced inflammatory signaling and is activated by point mutations.

Authors:  Paarth B Dodhiawala; Namrata Khurana; Daoxiang Zhang; Yi Cheng; Lin Li; Qing Wei; Kuljeet Seehra; Hongmei Jiang; Patrick M Grierson; Andrea Wang-Gillam; Kian-Huat Lim
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

3.  The Attenuation of 14-3-3ζ is Involved in the Caffeic Acid-Blocked Lipopolysaccharide-Stimulated Inflammatory Response in RAW264.7 Macrophages.

Authors:  Ming Lu; Yi Dai; Miao Xu; Chi Zhang; Yuhong Ma; Ping Gao; Mengying Teng; Kailin Jiao; Guangming Huang; Jianping Zhang; Ye Yang; Zhiping Chu
Journal:  Inflammation       Date:  2017-10       Impact factor: 4.092

4.  An inflammatory bowel disease-risk variant in INAVA decreases pattern recognition receptor-induced outcomes.

Authors:  Jie Yan; Matija Hedl; Clara Abraham
Journal:  J Clin Invest       Date:  2017-04-24       Impact factor: 14.808

5.  The Crystal Structure of Cancer Osaka Thyroid Kinase Reveals an Unexpected Kinase Domain Fold.

Authors:  Sascha Gutmann; Alexandra Hinniger; Gabriele Fendrich; Peter Drückes; Sylvie Antz; Henri Mattes; Henrik Möbitz; Silvio Ofner; Niko Schmiedeberg; Aleksandar Stojanovic; Sebastien Rieffel; André Strauss; Thomas Troxler; Ralf Glatthar; Helmut Sparrer
Journal:  J Biol Chem       Date:  2015-04-27       Impact factor: 5.157

6.  ABIN2 Function Is Required To Suppress DSS-Induced Colitis by a Tpl2-Independent Mechanism.

Authors:  Sambit K Nanda; Tsunehisa Nagamori; Mark Windheim; Sylvia Amu; Gabriella Aviello; Janet Patterson-Kane; J Simon C Arthur; Steven C Ley; Padraic Fallon; Philip Cohen
Journal:  J Immunol       Date:  2018-10-24       Impact factor: 5.422

7.  Roles of the TRAF6 and Pellino E3 ligases in MyD88 and RANKL signaling.

Authors:  Sam Strickson; Christoph H Emmerich; Eddy T H Goh; Jiazhen Zhang; Ian R Kelsall; Thomas Macartney; C James Hastie; Axel Knebel; Mark Peggie; Francesco Marchesi; J Simon C Arthur; Philip Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-12       Impact factor: 11.205

8.  Aberrant expression of COT is related to recurrence of papillary thyroid cancer.

Authors:  Jandee Lee; Seonhyang Jeong; Jae Hyun Park; Cho Rok Lee; Cheol Ryong Ku; Sang-Wook Kang; Jong Ju Jeong; Kee-Hyun Nam; Dong Yeob Shin; Eun Jig Lee; Woong Youn Chung; Young Suk Jo
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

Review 9.  Tumor progression locus 2 (Tpl2) kinase as a novel therapeutic target for cancer: double-sided effects of Tpl2 on cancer.

Authors:  Hye Won Lee; Han Yong Choi; Kyeung Min Joo; Do-Hyun Nam
Journal:  Int J Mol Sci       Date:  2015-02-25       Impact factor: 5.923

10.  Analysis of protein expression in periodontal pocket tissue: a preliminary study.

Authors:  Emanuela Monari; Aurora Cuoghi; Elisa Bellei; Stefania Bergamini; Andrea Lucchi; Aldo Tomasi; Pierpaolo Cortellini; Davide Zaffe; Carlo Bertoldi
Journal:  Proteome Sci       Date:  2015-12-30       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.